title: Long-term follow-up of a randomized trial of graft-versus-host disease prevention by methotrexate/cyclosporine versus methotrexate alone in patients given marrow grafts for severe aplastic anemia.
authors.forename: R
authors.initials: R
authors.lastname: Storb
authors.forename: W
authors.initials: W
authors.lastname: Leisenring
authors.forename: H J
authors.initials: HJ
authors.lastname: Deeg
authors.forename: C
authors.initials: C
authors.lastname: Anasetti
authors.forename: F
authors.initials: F
authors.lastname: Appelbaum
authors.forename: W
authors.initials: W
authors.lastname: Bensinger
authors.forename: C D
authors.initials: CD
authors.lastname: Buckner
authors.forename: R
authors.initials: R
authors.lastname: Clift
authors.forename: K
authors.initials: K
authors.lastname: Doney
authors.forename: J
authors.initials: J
authors.lastname: Hansen
mesh_terms: D000741:Anemia, Aplastic / Q000628:therapy*; D016026:Bone Marrow Transplantation; D016572:Cyclosporine / Q000008:administration & dosage / Q000627:therapeutic use*; D006086:Graft vs Host Disease / Q000517:prevention & control*; D006801:Humans; D008727:Methotrexate / Q000008:administration & dosage / Q000627:therapeutic use*; D011446:Prospective Studies
chemical_list: D016572:Cyclosporine; D008727:Methotrexate